FindTrial
Sign In

Treatment of primary liver cancer with traditional Chinese medicine: a retrospective cohort study based on the real world

Study of constructing evidence-based evidence of primary carcinoma of the liver based on real-world clinical data of TCM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016117
Enrollment
Unknown
Registered
2018-05-13
Start date
2018-05-15
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary carcinoma of liver

Interventions

TCM treatment group:TCM treatment
Non-TCM treatment group:Other treatments except TCM

Sponsors

The first affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who meet the histopathological or imaging diagnostic criteria for primary liver cancer (2015 edition); Male or female patients aged 18 or above; Patients who have access to complete medical information.

Exclusion criteria

Exclusion criteria: All patients whose original electronic medical records or paper medical records are incomplete; Patients who were hospitalized once and for less than 24 hours; Patients who were unable to obtain follow-up information after diagnosis.

Design outcomes

Primary

MeasureTime frame
survival rate;—

Secondary

MeasureTime frame
survival time;—

Countries

China

Contacts

Public ContactShao Mingyi

The first affiliated Hospital of Henan University of Chinese Medicine

shmy1016@163.com+86 13523710661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026